| Date |
Title |
Action |
| January 2020 |
Roche Pharmaceuticals Pre-Budget Submission 2020-21 |
Download |
| April 2019 |
Roche Election Policy Agenda 2019 |
Download |
| November 2017 |
Access to Medicines for Rare Diseases |
Download |
| February 2017 |
Access to Medicines Under the PBS |
Download |
| October 2016 |
Access to Medicines Outside of Public Funding |
Download |
| December 2016 |
Biosimilars |
Download |
| October 2017 |
Cancer Medicines |
Download |
| October 2016 |
Clinical Data Transparency |
Download |
| September 2018 |
Clinical Trials in Australia |
Download |
| October 2016 |
Engaging with Healthcare Professionals (HCPs) and health-related organisations
|
Download |
| October 2016 |
Engaging with Health Consumer Organisations |
Download |
| October 2016 |
Ethical and Sustainable Business |
Download |
| February 2017 |
Health Technology Assessment |
Download |
| September 2018 |
Intellectual Property in Medicines |
Download |
| September 2016 |
Personalised Healthcare |
Download |
| February 2017 |
Pricing |
Download |
| October 2017 |
Regulatory Assessment of Prescription Medicines |
Download |
| December 2017 |
Roche Pre-Budget Submission 2017-18 |
Download |
| February 2017 |
Value of Medicines Innovation |
Download |
